Thomas Österberg
10Patents
7h-index
8Co-inventors
59Inventor score
Filing activity: Feb 10, 1982 → Sep 13, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5972885A | Method for treatment of hemophilia by extravascular administration of factor VIII deletion derivatives | Human Necessities | 99 | Expired |
| US5733873A | Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer | Emerging Cross-Sectional Technologies | 89 | Expired |
| US5919766A | Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer | Emerging Cross-Sectional Technologies | 63 | Expired |
| US5925739A | Pharmaceutical formulation for subcutaneous intramuscular or intradermal administration of factor VIII | Human Necessities | 50 | Expired |
| US5962650A | Oxygen-reduced aqueous solution of factor VIII | Human Necessities | 44 | Expired |
| US4437017A | Arrangement for hydroelectric power plants | Emerging Cross-Sectional Technologies | 17 | Expired |
| US5919908A | Protein formulation comprising coagulation factor VIII or factor IX in an aqueous solution | Emerging Cross-Sectional Technologies | 10 | Expired |
| US11532788B2 | Laminated module | Emerging Cross-Sectional Technologies | 2 | Active |
| US11785788B2 | Laminated solar cell module and method of manufacturing said module | Emerging Cross-Sectional Technologies | 0 | Active |
| US11696457B2 | Solar cell lamination | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.